Literature DB >> 24832031

Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?

Joy B Parrish1, Osman Farooq, Bianca Weinstock-Guttman.   

Abstract

Pediatric-onset multiple sclerosis is relatively rare and research regarding disease characteristics is in its infancy. Regardless, there are a growing number of studies finding early cognitive deficits in this population. There are some similarities in outcomes to those seen in the adult-onset multiple sclerosis population, but also several important differences. With specific regard to cognitive functioning in pediatric-onset multiple sclerosis, there is evidence of deficit in nearly a third of patients, with impairment primarily in areas of processing speed, visual-spatial processing and language. There are additional findings of fatigue and depression that impact functional outcomes requiring further attention in assessment and treatment considerations. This paper also explores other areas requiring increased focus, including treatment and outcomes, neuroimaging and additional disease-modifying factors (comorbidities, socioeconomic status, race and so on).

Entities:  

Mesh:

Year:  2014        PMID: 24832031     DOI: 10.2217/nmt.14.4

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  3 in total

1.  Computer-assisted rehabilitation of attention in pediatric multiple sclerosis and ADHD patients: a pilot trial.

Authors:  Marta Simone; Rosa Gemma Viterbo; Lucia Margari; Pietro Iaffaldano
Journal:  BMC Neurol       Date:  2018-06-08       Impact factor: 2.474

Review 2.  Current Advances in Pediatric Onset Multiple Sclerosis.

Authors:  Kristen S Fisher; Fernando X Cuascut; Victor M Rivera; George J Hutton
Journal:  Biomedicines       Date:  2020-03-28

3.  A Randomized Computer-Assisted Rehabilitation Trial of Attention in Pediatric Multiple Sclerosis: A Post Hoc Analysis.

Authors:  Marta Simone; Rosa Gemma Viterbo; Lucia Margari; Pietro Iaffaldano
Journal:  Brain Sci       Date:  2021-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.